These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 13880058)

  • 1. [Effect of the fibrinolytic inhibitor from peanuts on the process of hypercholesterolic atherogenesis].
    COCCHERI S; LORETI A; GENNARI P; BEGHELLI V
    Boll Soc Ital Biol Sper; 1962 Jan; 38():64-7. PubMed ID: 13880058
    [No Abstract]   [Full Text] [Related]  

  • 2. [SIGNIFICANCE OF FIBRINOLYSIS IN EXPERIMENTAL ATHEROGENESIS DUE TO HYPERCHOLESTEROLIC DIET. I. EFFECTS OF A DIET RICH IN FIBRINOLYTIC INHIBITOR].
    COCCHERI S; BORGATTI E; LORETI A; GENNARI P
    G Clin Med; 1964 Dec; 45():1434-52. PubMed ID: 14320253
    [No Abstract]   [Full Text] [Related]  

  • 3. [Plasmatic fibrinolysis in experimental hypercholesterolic atheromasia].
    COCCHERI S; BEGHELLI V; LAMIERI C; GENNARI P
    Boll Soc Ital Biol Sper; 1962 Jan; 38():62-4. PubMed ID: 13880056
    [No Abstract]   [Full Text] [Related]  

  • 4. [FIBRINOLYTIC ACTIVITY IN ATHEROSCLEROSIS].
    RAYNAUD R; BROCHIER M; GRIGUER P
    Actual Cardiol Angeiol Int (Paris); 1964; 13():159-66. PubMed ID: 14240464
    [No Abstract]   [Full Text] [Related]  

  • 5. Peanuts, peanut oil, and fat free peanut flour reduced cardiovascular disease risk factors and the development of atherosclerosis in Syrian golden hamsters.
    Stephens AM; Dean LL; Davis JP; Osborne JA; Sanders TH
    J Food Sci; 2010 May; 75(4):H116-22. PubMed ID: 20546405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme.
    AMBRUS CM; MARKUS G
    Am J Physiol; 1960 Sep; 199():491-4. PubMed ID: 13682944
    [No Abstract]   [Full Text] [Related]  

  • 7. [EARLY ARTERIAL CHANGES IN EXPERIMENTAL ATHEROSCLEROSIS IN MONKEYS].
    CHAZOV EI; USHKALOV AF; KLEMBOVSKII AI; BYKOVSKOI KN
    Arkh Patol; 1963; 25():29-37. PubMed ID: 14147685
    [No Abstract]   [Full Text] [Related]  

  • 8. Antifibrinolytic activity in primary carcinoma of the liver.
    KWAAN HC; LO R; MCFADZEAN AJ
    Clin Sci; 1959 May; 18():251-61. PubMed ID: 14413062
    [No Abstract]   [Full Text] [Related]  

  • 9. The relationship between blood fibrinolytic activity, serum lipoproteins and serum cholesterol in atherosclerotic arterial disease.
    NESTEL PJ
    Australas Ann Med; 1960 Aug; 9():234-6. PubMed ID: 13728418
    [No Abstract]   [Full Text] [Related]  

  • 10. AORTIC ARTERIOSCLEROSIS IN RABBITS. FED INHIBITORS OF FIBRINOLYSIS.
    KWAAN HC; ASTRUP T
    Arch Pathol; 1964 Nov; 78():474-82. PubMed ID: 14200668
    [No Abstract]   [Full Text] [Related]  

  • 11. ANTIHEPARIN AND ANTIFIBRINOLYTIC ACTIVITY OF BLOOD IN PATIENTS WITH ATHEROSCLEROSIS.
    MYASNIKOV AL; CHAZOV EI
    Am Heart J; 1964 Jan; 67():18-22. PubMed ID: 14110659
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antifibrinolytic activity in the blood and its therapeutic increase in gynecological hemorrhages].
    KOUTSKY J; KUBES Z; RYBAK M; HILADOVEC J; MANSFELD V
    Gynaecologia; 1961 Apr; 151():301-13. PubMed ID: 13753564
    [No Abstract]   [Full Text] [Related]  

  • 13. [Proposal for new technics for the study of antifibrinolysin in man and in experimental animals].
    TURPINI R
    Haematologica; 1959; 44():445-56. PubMed ID: 13839992
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study on the inhibition effect of caprolactam and analogous compounds on kinins and factors of the fibrinolytic system].
    Doleschel W; Auerswald W
    Wien Med Wochenschr; 1967 Feb; 117(6):137-42. PubMed ID: 4298791
    [No Abstract]   [Full Text] [Related]  

  • 15. The antiplasmin effect of plasma fractions.
    RYBAK M; REJNEK J
    Clin Chim Acta; 1959 May; 4(3):364-8. PubMed ID: 13663237
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasmatic and platelet anti-plasmins and anti-activators.
    Den Ottolander GJ; Leijnse B; Cremer-Elfrink HM
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):404-15. PubMed ID: 4232162
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative studies of fibrinolytic inhibitors in vitro.
    Maki M; Beller FK
    Thromb Diath Haemorrh; 1966 Dec; 16(3):668-86. PubMed ID: 4231539
    [No Abstract]   [Full Text] [Related]  

  • 18. [2 cases of acute fibrinolysis treated with success by plasmin inhibitor. Survival. Secondary death].
    MATHEY J; CORMIER JM; AIGUEPERSE J; LALARDRIE JP; HAEGEL A
    Mem Acad Chir (Paris); 1961 Feb 1-8; 87():155-61. PubMed ID: 13768100
    [No Abstract]   [Full Text] [Related]  

  • 19. Depressed endogenous fibrinolytic activity in essential hypertension.
    Tsapogas MJ; Peabody RA; Wu KT; Devaraj KT; Eckert C
    J Cardiovasc Surg (Torino); 1974; 15(6):651-4. PubMed ID: 4281429
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum antiplasmin and plasmin in rheumatoid arthritis.
    THOMAS DP; DINGLE JT
    Ann Rheum Dis; 1955 Jun; 14(2):195-7. PubMed ID: 14388598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.